Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ - Fiorentino, D F; Chung, L S; Christopher-Stine, L (Arthritis Rheum, 2013)
et al.